KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	151,385	166,982	257,943	233,403	529,520	242,129
Market Cap Growth	-12.54%	-35.26%	10.51%	-55.92%	118.69%	-
Enterprise Value	158,627	151,067	248,815	222,946	528,191	235,248
Last Close Price	13880.00	15310.00	23572.66	21282.30	48172.24	22004.51
PE Ratio	104.61	44.04	3079.40	-	83.15	76.65
Forward PE	-	82.10	82.10	82.10	112.13	39.78
PS Ratio	1.77	2.05	3.10	2.88	6.65	3.39
PB Ratio	2.13	2.34	3.76	3.90	9.21	5.21
P/TBV Ratio	2.25	2.48	3.96	4.10	9.72	5.50
P/FCF Ratio	-	34.81	78.44	40.14	114.12	-
P/OCF Ratio	39.92	20.75	53.52	28.19	73.62	-
EV/Sales Ratio	1.86	1.86	2.99	2.75	6.64	3.29
EV/EBITDA Ratio	18.57	17.01	28.75	26.02	71.46	34.47
EV/EBIT Ratio	28.69	24.82	42.60	36.03	105.34	51.10
EV/FCF Ratio	-8.84	31.49	75.67	38.34	113.83	-
Debt / Equity Ratio	0.53	0.32	0.51	0.91	0.94	0.30
Debt / EBITDA Ratio	5.42	2.58	4.03	6.38	7.27	2.04
Debt / FCF Ratio	-	4.77	10.60	9.40	11.58	-
Asset Turnover	0.70	0.70	0.66	0.62	0.76	0.97
Inventory Turnover	2.38	2.46	2.59	2.67	2.40	2.30
Quick Ratio	1.16	2.76	1.89	1.14	3.13	1.13
Current Ratio	1.71	3.81	2.56	1.41	3.81	1.79
Return on Equity (ROE)	2.05%	5.42%	0.13%	-1.91%	12.25%	8.64%
Return on Assets (ROA)	2.01%	3.26%	2.89%	2.97%	2.97%	3.89%
Return on Capital (ROIC)	2.36%	3.85%	3.35%	3.43%	3.65%	5.53%
Return on Capital Employed (ROCE)	4.50%	6.50%	6.60%	10.10%	4.80%	9.10%
Earnings Yield	0.96%	2.27%	0.03%	-0.48%	1.20%	1.31%
FCF Yield	-11.86%	2.87%	1.27%	2.49%	0.88%	-1.18%
Payout Ratio	37.65%	14.38%	651.04%	-	8.56%	13.91%
Buyback Yield / Dilution	-16.03%	-15.33%	3.63%	1.22%	-12.80%	-10.95%

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.